ENDRA Life Sciences (NDRA) Net Margin: 2016-2018
Historic Net Margin for ENDRA Life Sciences (NDRA) over the last 2 years, with Mar 2018 value amounting to -45,761.31%.
- ENDRA Life Sciences' Net Margin was N/A to -45,761.31% in Q1 2018 from the same period last year, while for Mar 2018 it was -2,085.17%, marking a year-over-year change of. This contributed to the annual value of -10,607.97% for FY2024, which is 842326.00% down from last year.
- As of Q1 2018, ENDRA Life Sciences' Net Margin stood at -45,761.31%, which was down 36.61% from -33,498.39% recorded in Q4 2017.
- In the past 5 years, ENDRA Life Sciences' Net Margin registered a high of 368,239.39% during Q2 2016, and its lowest value of -45,761.31% during Q1 2018.
- In the last 3 years, ENDRA Life Sciences' Net Margin had a median value of -316.69% in 2017 and averaged 40,901.91%.
- Data for ENDRA Life Sciences' Net Margin shows a maximum YoY crashed of 37,071,774bps (in 2017) over the last 5 years.
- ENDRA Life Sciences' Net Margin (Quarterly) stood at -133.61% in 2016, then plummeted by 3,336,478bps to -33,498.39% in 2017, then reached -45,761.31% in 2018.
- Its last three reported values are -45,761.31% in Q1 2018, -33,498.39% for Q4 2017, and -316.69% during Q3 2017.